Journal of thrombosis and haemostasis : JTH
-
J. Thromb. Haemost. · Jun 2018
Randomized Controlled Trial Multicenter Study Comparative StudyClinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study.
Essentials Cancer patients receiving anticoagulants for venous thromboembolism have an elevated bleeding risk. This secondary analysis of CATCH assessed characteristics of clinically relevant bleeding (CRB). CRB occurs in 15% of cancer patients with thrombosis using therapeutic doses of anticoagulation. After multivariate analysis, risk factors for CRB were age >75 years and intracranial malignancy.